Figure 4
Overall survival according to AID expression. Patients with AID-negative lymphomas have a longer median survival than patients with AID-positive small lymphocytic lymphomas (130 vs 61 months).
Figure 4 | Modern Pathology
Overall survival according to AID expression. Patients with AID-negative lymphomas have a longer median survival than patients with AID-positive small lymphocytic lymphomas (130 vs 61 months).
